Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

They’ve survived near-death diagnoses, endured multiple organ transplants, and fought back from physical collapse. Now, Omar ...

XORTX Therapeutics Inc. ("XORTX” or the "Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical ...

My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is so confusing. I have early Alzheimer's and have trouble organizing my ...

Hyderabad: A pilot study in Andhra Pradesh has revealed a gap in kidney disease awareness, with chronic kidney disease (CKD) ...

Natural sweeteners like honey or maple syrup, used sparingly, could be a better choice for those worried about kidney health.

A new type of drug, known as an anti-necrotic, could be the first drug ever approved to treat aging itself. The drug, which ...

A Vanderburgh County resident has Indiana’s first case of West Nile virus for the year, the Indiana Department of Health ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the best high-return penny stocks to buy now. On July 14, 2025, Akebia ...

ProKidney Corp. (NASDAQ:PROK) is a late-stage biotechnology company focused on developing a cell therapy called rilparencel ...